10.06USD-2.71%Mkt Cap: 311.12M $P/E: —2d ago
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is th…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap311.12M $
Enterprise Value349.40M $
Revenue (TTM)75.63M $
Gross Profit58.82M $
Net Income (TTM)-48.59M $
Revenue/Share2.522 USD
Last Price10.06 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees226
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-23.57
PEG—
EV/EBITDA-10.66
EV/Revenue4.62
P/S4.13
P/B-11.21
EPS (TTM)-1.40
EPS (Forward)-0.43
52W Range
3.22095% of range10.41
52W High10.41 USD
52W Low3.220 USD
Profitability
Gross Margin82.13%
Oper. Margin-31.59%
EBITDA Margin-43.32%
Profit Margin-67.85%
ROE291.81%
ROA-86.16%
Growth
Revenue Growth17.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.20M $
CapEx (TTM)1.74M $
FCF Margin-17.65%
FCF Yield-4.29%
Net Debt37.35M $
Net Debt/EBITDA-1.14
Balance Sheet
Debt/Equity-2.77
Current Ratio0.41
Quick Ratio0.31
Book Value/Sh-0.9000 USD
Cash/Share0.3600 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJun 30, 2020
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.11 USD
Upside (mean)+10.5%
Target Range8.134 USD – 14.11 USD
$8.134+10.5% to mean$14.11
# Analysts3
Ownership
Shares Out.30.93M
Float30.47M
Insiders1.51%
Institutions16.02%
Short Interest
Short Ratio9.4d
Short % Float8.51%
Short % Out.8.43%
Shares Short2.61M
Short (prev mo.)2.53M
Technical
SMA 505.261 (+91.2%)
SMA 2004.393 (+129.0%)
Beta1.85
S&P 52W Chg18.16%
Avg Vol (30d)548.85K
Avg Vol (10d)1.32M
Technical Indicators
RSI (14)80.8
MACD1.2652
MACD Signal0.8435
MACD Hist.+0.4217
BB Upper10.46 USD
BB Middle6.311 USD
BB Lower2.162 USD
BB Width131.50%
ATR (14)0.6944 USD
Vol Ratio (20d)0.46x